📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. (2018)

First Author: Vale CL

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdy071

PubMed Identifier: 29788164

Publication URI: http://europepmc.org/abstract/MED/29788164

Type: Journal Article/Review

Volume: 29

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 5

ISSN: 0923-7534